Torrent Pharma acquires two women healthcare brands from Novartis

While company did not disclose deal size, it is estimated to be close to Rs 500 cr

Ahmedabad-based Torrent Pharma has completed the acquisition of women healthcare brands Regestrone and Pregachieve for India from Swiss pharma major Novartis AG. While the company did not disclose the deal size, it is estimated to be close to Rs 500 crore.

Torrent was in talks to acquire these brands since the last few months and had entered into a pact with Novartis last month to acquire the two brands. Both the brands are prescribed by gynaecologists for management of abnormal uterine bleeding, peri and post menopausal symptoms and infertility.

Torrent said in a release here that women healthcare is an important therapy